China: Retail price management case highlights clashing approaches to antitrust law
A ruling by the Shanghai Intermediate People’s Court against Rainbow Medical, which alleged Johnson & Johnson hampered competition with a contract between the two parties, has been appealed to the Shanghai Higher People’s Court. According to a report, the situation is part of a larger trend of conflicting governmental approaches to retail price maintenance cases under the PRC Anti-monopoly Law. Quoted is antitrust lawyer Zhaofeng Zhou, noting that in this particular case the court used an approach “similar to the US rule of reason,” while the National Development and Reform Commission, China’s antitrust authority, used the per se illegal approach “commonly found in the EU.”
Featured News
Trump Administration Defends Pentagon Blacklisting of AI Firm Anthropic in Court Filing
Mar 18, 2026 by
CPI
BMG Sues Anthropic Over Alleged Use of Song Lyrics in AI Training
Mar 18, 2026 by
CPI
Google Proposes New Search Controls Amid UK Competition Scrutiny
Mar 18, 2026 by
CPI
US Appeals Court Revives Whistleblower Case Against Major Drugmakers Over Pricing Program
Mar 18, 2026 by
CPI
Possible Compromise Emerging on Stablecoin Yield Payments in Senate Market-Structure Bill
Mar 18, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece